|

Diabetes Clinical Trials in Raleigh, NC

50 recruiting studies within 50 miles

Phase
Trial Phase Dist.
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2<1 mi
A Food As Medicine Approach to Address Food Insecurity in Rural North CarolinaN/A<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3<1 mi
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TLPhase 4<1 mi
Assessment of AI Program 'DRISTi' as a Screening Tool—<1 mi
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot UlcersN/A<1 mi
A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusPhase 2<1 mi
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusPhase 3<1 mi
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMPhase 3<1 mi
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusPhase 3<1 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinPhase 3<1 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesPhase 3<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 38 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background InsulinPhase 38 mi
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have DiabetesPhase 311 mi
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and DiabetesPhase 311 mi
Personalized Environment and Genes Study—15 mi
Intraoperative OCT Guidance of Intraocular Surgery II—21 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPhase 421 mi
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US—21 mi
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 DiabetesN/A21 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/A21 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 421 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1DPhase 121 mi
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)N/A21 mi
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.Phase 121 mi
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot UlcersPhase 221 mi
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)N/A21 mi
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Phase 321 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 225 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 225 mi
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and DiabetesN/A25 mi
Healthy Living Anson StudyN/A25 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesPhase 225 mi
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMARTN/A25 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot UlcersN/A25 mi
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesPhase 425 mi
SPYRAL GEMINI Pilot StudyN/A25 mi
Registry for Stage 2 Type 1 Diabetes—25 mi
HLA Demographics Study in Adults With Type 1 Diabetes—25 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 325 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesPhase 325 mi
Rare and Atypical Diabetes Network—25 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 325 mi
Transformative Research in Diabetic Nephropathy—25 mi
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)N/A25 mi
CGM for Management of Type 2 Diabetes in PregnancyN/A25 mi
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)N/A25 mi
Kidney Precision Medicine Project—25 mi
Integrating New Skills Into Diabetes Education With CGMN/A25 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.